News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,354 Results
Type
Article (55038)
Company Profile (274)
Press Release (636042)
Multimedia
Podcasts (108)
Webinars (13)
Section
Business (196006)
Career Advice (2830)
Deals (35476)
Drug Delivery (121)
Drug Development (83089)
Employer Resources (171)
FDA (16953)
Job Trends (15930)
News (341925)
Policy (34600)
Tag
Academia (2872)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (49775)
ALS (102)
Alzheimer's disease (1459)
Antibody-drug conjugate (ADC) (158)
Approvals (16912)
Artificial intelligence (303)
Autoimmune disease (29)
Automation (17)
Bankruptcy (359)
Best Places to Work (11917)
BIOSECURE Act (21)
Biosimilars (120)
Biotechnology (163)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (310)
Cancer (2440)
Cardiovascular disease (207)
Career advice (2385)
Career pathing (34)
CAR-T (175)
Cell therapy (480)
Cervical cancer (21)
Clinical research (67708)
Collaboration (921)
Company closure (2)
Compensation (338)
Complete response letters (30)
COVID-19 (2834)
CRISPR (49)
C-suite (273)
Cystic fibrosis (110)
Data (2363)
Decentralized trials (2)
Denatured (33)
Depression (55)
Diabetes (299)
Diagnostics (6527)
Digital health (20)
Diversity (7)
Diversity, equity & inclusion (40)
Drug discovery (125)
Drug pricing (130)
Drug shortages (32)
Duchenne muscular dystrophy (104)
Earnings (76461)
Editorial (47)
Employer branding (22)
Employer resources (150)
Events (100472)
Executive appointments (786)
FDA (18367)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (801)
Gene editing (120)
Generative AI (28)
Gene therapy (357)
GLP-1 (846)
Government (4827)
Grass and pollen (6)
Guidances (161)
Healthcare (19150)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (153)
Indications (29)
Infectious disease (2997)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (57)
Intellectual property (103)
Interviews (524)
IPO (15789)
IRA (48)
Job creations (4416)
Job search strategy (1995)
Kidney cancer (11)
Labor market (39)
Layoffs (554)
Leadership (24)
Legal (8184)
Liver cancer (82)
Lung cancer (344)
Lymphoma (159)
Machine learning (9)
Management (60)
Manufacturing (354)
MASH (82)
Medical device (13403)
Medtech (13408)
Mergers & acquisitions (20242)
Metabolic disorders (800)
Multiple sclerosis (90)
NASH (23)
Neurodegenerative disease (115)
Neuropsychiatric disorders (33)
Neuroscience (2075)
NextGen: Class of 2025 (6948)
Non-profit (4879)
Now hiring (37)
Obesity (428)
Opinion (263)
Ovarian cancer (83)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (163)
Partnered (22)
Patents (249)
Patient recruitment (117)
Peanut (50)
People (58233)
Pharmaceutical (87)
Pharmacy benefit managers (24)
Phase I (21008)
Phase II (29608)
Phase III (22505)
Pipeline (1420)
Policy (178)
Postmarket research (2759)
Preclinical (8581)
Press Release (65)
Prostate cancer (112)
Psychedelics (36)
Radiopharmaceuticals (246)
Rare diseases (428)
Real estate (6215)
Recruiting (70)
Regulatory (23891)
Reports (37)
Research institute (2544)
Resumes & cover letters (432)
Rett syndrome (6)
RNA editing (4)
RSV (50)
Schizophrenia (84)
Series A (140)
Series B (97)
Service/supplier (13)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (158)
Sponsored (28)
Startups (3768)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (58)
The Weekly (73)
Vaccines (815)
Venture capitalists (45)
Weight loss (302)
Women's health (34)
Worklife (20)
Date
Today (138)
Last 7 days (976)
Last 30 days (3179)
Last 365 days (32061)
2025 (11853)
2024 (34621)
2023 (39506)
2022 (50358)
2021 (54986)
2020 (54381)
2019 (48035)
2018 (36865)
2017 (33925)
2016 (33467)
2015 (38107)
2014 (30416)
2013 (25508)
2012 (27393)
2011 (28022)
2010 (25515)
Location
Africa (976)
Alabama (57)
Alaska (7)
Arizona (186)
Arkansas (14)
Asia (42196)
Australia (6945)
California (6288)
Canada (1939)
China (549)
Colorado (276)
Connecticut (271)
Delaware (138)
Europe (94324)
Florida (887)
Georgia (200)
Hawaii (1)
Idaho (59)
Illinois (558)
India (27)
Indiana (328)
Iowa (9)
Japan (176)
Kansas (106)
Kentucky (27)
Louisiana (12)
Maine (69)
Maryland (894)
Massachusetts (4372)
Michigan (222)
Minnesota (406)
Mississippi (2)
Missouri (86)
Montana (26)
Nebraska (25)
Nevada (61)
New Hampshire (69)
New Jersey (1709)
New Mexico (31)
New York (1761)
North Carolina (1032)
North Dakota (9)
Northern California (2702)
Ohio (201)
Oklahoma (13)
Oregon (39)
Pennsylvania (1313)
Puerto Rico (14)
Rhode Island (33)
South America (1339)
South Carolina (25)
South Dakota (1)
Southern California (2408)
Tennessee (106)
Texas (885)
United States (23130)
Utah (198)
Virginia (165)
Washington D.C. (68)
Washington State (560)
West Virginia (3)
Wisconsin (58)
691,354 Results for "maat pharma sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)
May 12, 2025
·
5 min read
Press Releases
MaaT Pharma Presents Preclinical Data at AACR Annual Meeting Demonstrating Immune Activation and Anti-Tumor Activity of MaaT034
April 28, 2025
·
5 min read
Press Releases
MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2025
May 13, 2025
·
7 min read
Press Releases
MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT
April 8, 2025
·
4 min read
Press Releases
MaaT Pharma To Present New Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies
March 31, 2025
·
5 min read
Press Releases
MaaT Pharma Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for MaaT013
March 11, 2025
·
6 min read
Press Releases
MaaT Pharma Announces Initiation of Coverage of its Stock by H.C. Wainwright & Co
April 7, 2025
·
2 min read
Press Releases
MaaT Pharma Completes a Capital Increase of €13 Million with Historical Shareholders and Announces 2024 Annual Results
March 27, 2025
·
20 min read
Press Releases
MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in Acute Graft-versus-Host Disease
March 18, 2025
·
6 min read
Autoimmune disease
MaaT Clears Phase III in GVHD, Eyes European Submission By Midyear
MaaT013 in 2022 was put under clinical hold by the FDA, which cited safety and efficacy concerns with the sample-pooling method used to produce the investigational therapy. The hold was lifted in April 2023.
January 9, 2025
·
2 min read
·
Tristan Manalac
1 of 69,136
Next
